IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 195 filers reported holding IMMUNOGEN INC in Q4 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $239 | +6.2% | 50 | 0.0% | 0.00% | – |
| Q2 2022 | $225 | -5.5% | 50 | 0.0% | 0.00% | – |
| Q1 2022 | $238 | -35.8% | 50 | 0.0% | 0.00% | – |
| Q4 2021 | $371 | +30.6% | 50 | 0.0% | 0.00% | – |
| Q3 2021 | $284 | -13.9% | 50 | 0.0% | 0.00% | – |
| Q2 2021 | $330 | -18.5% | 50 | 0.0% | 0.00% | – |
| Q1 2021 | $405 | +25.4% | 50 | 0.0% | 0.00% | – |
| Q4 2020 | $323 | +79.4% | 50 | 0.0% | 0.00% | – |
| Q3 2020 | $180 | -21.7% | 50 | 0.0% | 0.00% | – |
| Q2 2020 | $230 | +34.5% | 50 | 0.0% | 0.00% | – |
| Q1 2020 | $171 | -32.9% | 50 | 0.0% | 0.00% | – |
| Q4 2019 | $255 | +110.7% | 50 | 0.0% | 0.00% | – |
| Q3 2019 | $121 | +11.0% | 50 | 0.0% | 0.00% | – |
| Q2 2019 | $109 | -19.9% | 50 | 0.0% | 0.00% | – |
| Q1 2019 | $136 | -43.3% | 50 | 0.0% | 0.00% | – |
| Q4 2018 | $240 | -49.4% | 50 | 0.0% | 0.00% | – |
| Q3 2018 | $474 | -2.7% | 50 | 0.0% | 0.00% | – |
| Q2 2018 | $487 | -7.4% | 50 | 0.0% | 0.00% | – |
| Q1 2018 | $526 | +63.9% | 50 | 0.0% | 0.00% | – |
| Q4 2017 | $321 | – | 50 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 1,375,900 | $6,329,000 | 1.08% |
| Redmile Group, LLC | 12,006,979 | $55,232,000 | 1.02% |
| Birchview Capital, LP | 190,000 | $874,000 | 0.53% |
| Fernwood Investment Management, LLC | 179,340 | $825,000 | 0.41% |
| HealthCor Management, L.P. | 1,200,000 | $5,520,000 | 0.23% |
| Grace Capital | 49,500 | $228,000 | 0.20% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $479,000 | 0.19% |
| Virtus ETF Advisers LLC | 79,795 | $367,000 | 0.17% |
| PINNACLE ASSOCIATES LTD | 1,087,034 | $5,000,000 | 0.12% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 100,000 | $460,000 | 0.12% |